Dynamic Optimization of Target Oxygen Saturation Range in Preterm Infants Using Heart Rate Characteristics: Secondary Analysis of Two Overlapping Randomized Controlled Trials
Sunday, April 30, 2023
11:00 AM – 11:15 AM ET
Location: Convention Center: 145 AB
Publication Number: 2345.1
William E. King, MPSC, Charlottesville, VA, United States; Vivek Shukla, University of Alabama at Birmingham, Birmingham, AL, United States; Clyde Wright, University of Colorado School of Medicine, Aurora, CO, United States; Urvi Jhaveri Sanghvi, Children's Hospital Colorado, Centennial, CO, United States; Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States; Colm P. Travers, University of Alabama School of Medicine, Birmingham, AL, United States; Robert L. Schelonka, OHSU, Lake Oswego, OR, United States; Waldemar A. Carlo, University of Alabama School of Medicine, Birmingham, AL, United States
Presenting Author(s)
William E. King, IV, MS
CEO MPSC Charlottesville, Virginia, United States
Disclosure(s):
William E. King, MS, IV: Medical Predictive Science Corporation (Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Vivek Shukla, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Clyde Wright, MD: Chiesi (Terminated, December 31, 2022) (Products/Services: Consultant)
Urvi Jhaveri Sanghvi, PhD, RN: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Namasivayam Ambalavanan, MD: ResBiotic and AlveolusBio (Ongoing) (Products/Services: Advisory Committee, Intellectual Property including patent beneficiary and royalties); Shire and OakHill Bio (Ongoing) (Products/Services: Consultant)
Colm P. Travers, MD: No financial relationships to disclose
Robert L. Schelonka, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Waldemar A. Carlo, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
